Pristine Medical Products

Werfen, a prominent leader in the field of specialized diagnostics, focuses on enhancing patient care through innovative solutions in areas such as hemostasis, acute care diagnostics, and transfusion medicine. With a commitment to quality and compliance, the company provides high-quality diagnostic systems and services to labs and hospitals across the globe. With the recent acquisition of Omixon, Werfen expands its expertise in Next Generation Sequencing technologies for transplant diagnostics, further solidifying its mission of delivering reliable and accurate diagnostic results. Emphasizing the value of its workforce, Werfen recognizes that its employees play a crucial role in achieving the company's goals and maintaining their standards of excellence. Generated from the website

Eloxx Pharmaceutical is a cutting-edge biopharmaceutical company based in Waltham, MA, specializing in the development of small molecule genetic therapies. With a scientific focus on correcting nonsense mutations and ribosomal mutations, their platform technologies have the potential to revolutionize the treatment of rare genetic diseases and cancer. Driven by their commitment to innovation, Eloxx is currently focused on developing CELX-02, a novel therapy for Alport Syndrome, a rare kidney disease. Their pipeline also includes promising treatments for other conditions such as RDEB, JEB, and FAP, all targeting the underlying genetic defects responsible for these diseases. With a strong emphasis on scientific research and development, Eloxx Pharmaceuticals is poised to make a significant impact in the field of genetic medicine.Generated from the website